BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.41.90//
CALSCALE:GREGORIAN
UID:32313064-6536-4130-a139-396237313566
BEGIN:VEVENT
UID:e57421d0e094b4acdde0a4271046e7808b2a23ab@swoogo.com
DTSTAMP:20260610T190116Z
DESCRIPTION:Therapeutic apheresis — encompassing therapeutic plasma exchang
 e (TPE)\, double filtration plasmapheresis (DFPP)\, cytapheresis\, cytokin
 e adsorption\, and immunoadsorption — has emerged as a viable extracorpore
 al treatment modality in small animal medicine. This lecture provides a co
 mprehensive\, evidence-based review of the current veterinary literature\,
  translational extrapolation from human medicine guidelines (ASFA 9th Edit
 ion\, 2023\; EXTRIP workgroup)\, indications by disease category\, patient
  selection criteria\, technical considerations\, and the horizon of emergi
 ng applications.
DTSTART:20260513T180000Z
DTEND:20260513T193000Z
LAST-MODIFIED:20260610T190116Z
LOCATION:https://idexx.swoogo.com/051326DufayetTherapeuticApharesisinVeteri
 naryMedicineCurrentEvidenceandClinicalApplication/v/e
SEQUENCE:0
STATUS:CONFIRMED
SUMMARY:05.13.26 Specialist Webinar Dufayet Therapeutic Apheresis in Veteri
 nary Medicine: Current Evidence and Clinical Applications for the Speciali
 st
TRANSP:OPAQUE
X-ALT-DESC;FMTTYPE=text/html:<p>Therapeutic apheresis — encompassing therap
 eutic plasma exchange (TPE)\, double filtration plasmapheresis (DFPP)\, cy
 tapheresis\, cytokine adsorption\, and immunoadsorption — has emerged as a
  viable extracorporeal treatment modality in small animal medicine. This l
 ecture provides a comprehensive\, evidence-based review of the current vet
 erinary literature\, translational extrapolation from human medicine guide
 lines (ASFA 9th Edition\, 2023\; EXTRIP workgroup)\, indications by diseas
 e category\, patient selection criteria\, technical considerations\, and t
 he horizon of emerging applications.</p>
BEGIN:VALARM
UID:64376266-3437-4666-b262-623830363833
ACTION:DISPLAY
DESCRIPTION:Therapeutic apheresis — encompassing therapeutic plasma exchang
 e (TPE)\, double filtration plasmapheresis (DFPP)\, cytapheresis\, cytokin
 e adsorption\, and immunoadsorption — has emerged as a viable extracorpore
 al treatment modality in small animal medicine. This lecture provides a co
 mprehensive\, evidence-based review of the current veterinary literature\,
  translational extrapolation from human medicine guidelines (ASFA 9th Edit
 ion\, 2023\; EXTRIP workgroup)\, indications by disease category\, patient
  selection criteria\, technical considerations\, and the horizon of emergi
 ng applications.
TRIGGER:-PT15M
END:VALARM
END:VEVENT
END:VCALENDAR